NCT02481635View on ClinicalTrials.gov

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Pancreatic Cancer

Interventions

DRUG

Gemcitabine

DRUG

Nab-paclitaxel

RADIATION

Radiation Therapy

PROCEDURE

Surgical Resection

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER

NCT02481635 - A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter